Bacterial Infections  >>  SQ-109  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SQ-109 / Sequella
NCT01585636: Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers

Completed
1
62
US
SQ109
Sequella, Inc., Quintiles, Inc.
Tuberculosis
02/07
02/07

Download Options